Goldman Sachs Currently Up Eight Consecutive Days, On Pace for Longest Winning Streak Since November 2022 — Data Talk
Goldman Sachs Group, Inc. (GS) is currently at $457.64, up $2.08 or 0.46%
--Would be new all-time high (Based on available data back to May 4, 1999)
--Currently up 10 of the past 11 days
--Currently up eight consecutive days; up 7.25% over this period
--Longest winning streak since Nov. 2, 2022, when it rose for nine straight trading days
--Best eight day stretch since the eight days ending April 26, 2024, when it rose 7.74%
--Up 7.25% month-to-date
--Up 18.63% year-to-date
--Up 43.24% from 52 weeks ago (May 12, 2023), when it closed at $319.50
--Would be a new 52-week closing high
--Up 57.86% from its 52-week closing low of $289.91 on Oct. 27, 2023
--Traded as high as $458.75; new all-time intraday high (Based on available data back to May 4, 1999)
--Up 0.7% at today's intraday high
--Contributed 13.66 points to the DJIA so far today
All data as of 10:41:27 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 10, 2024 10:57 ET (14:57 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Six Sports Betting and iGaming Stocks Trading at a Discount
-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations